Clinical Trial to Evaluate the Efficacy and Safety of YHP1701
A phase 3 trial registered on ClinicalTrials.gov. The registry status is completed. It enrolled 106 participants.
Also called NCT03103256
- Study
- In this atlas
Overview
- Design
- Interventional study; randomized; double masking; primary purpose treatment
- Phase
- Phase 3
- Enrolled
- 106 participants
- Sponsor
- Registry
-
NCT03103256
-
- Other papers using this trial's data
- A randomized, double-blind clinical trial to evaluate the efficacy and safety of a fixed-dose combination of amlodipine/rosuvastatin in patients with dyslipidemia and hypertension
- Started
- (actual)
- Primary completion
- (actual)
- Completion
- (actual)
- Countries
- South Korea
- Registry status
- Completed
Technical summary
Registry record NCT03103256. Randomized; double masking; primary purpose treatment. Start 2017-05-17 (actual); primary completion 2018-04-30 (actual). Results not posted.
The registry's words
Labels as the registry gives them, not rewritten.
- Brief title
- Clinical Trial to Evaluate the Efficacy and Safety of YHP1701
- Condition
- Hypertension and Hyperlipidemia
- Intervention (Drug)
- YHP1701
- Intervention (Drug)
- YHR1703
- Intervention (Drug)
- YHR1704
- Lead sponsor
- Yuhan Corporation
Record details
- Record id
cardio:ct-nct03103256- Content hash
764535d665daa8de8feb38b08067643553c86b2e74d4c324fc595867c8a6057b